Evidence map›Paper›PMID 28264848›Full record

ArticleAntimicrobial agents and chemotherapy2017

Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis.

C Garcia-de-la-Maria, Y Q Xiong, J M Pericas, Y Armero, A Moreno, N N Mishra, M J Rybak, T T Tran, C A Arias, P M Sullam and 2 more

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Sensitizing methicillin-resistantAntimicrobial agents and chemotherapy · 2024
    Article
  2. Article
  3. Article
  4. Development of High-Level Daptomycin Resistance inAntimicrobial agents and chemotherapy · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Mutations inAntimicrobial agents and chemotherapy · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

C Garcia-de-la-MariaHospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain.
Y Q XiongLA Biomedical Research Institute, Torrance, California, USA.
J M PericasHospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain.
Y ArmeroHospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain.
A MorenoHospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain.
N N MishraLA Biomedical Research Institute, Torrance, California, USA.
M J RybakAnti-Infective Research Laboratory, Wayne State University, Detroit, Michigan, USA.
T T TranUniversity of Texas School of Medicine, Houston, Texas, USA.
C A AriasUniversity of Texas School of Medicine, Houston, Texas, USA.
P M SullamVeterans Affairs Medical Center and the University of California, San Francisco, California, USA.
A S BayerLA Biomedical Research Institute, Torrance, California, USA.
J M MiroHospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain jmmiro@ub.edu.
Universitat de Barcelona · ESUniversity of California, Los Angeles · USConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESHospital Clínic de Barcelona · ESSan Francisco VA Medical Center · USWayne State University · US

Funding

STREPTOCOCCAL PLATELET BINDING AND ENDOCARDITISR01AI041513 · NIAID · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI SULLAM, PAUL M. · 1997 to 2019
$5.6M
Mechanisms for ligand binding by serine-rich adhesins of Gram-positive pathogensR01AI106987 · NIAID · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI IVERSON, T M, SULLAM, PAUL M. · 2014 to 2018
$3.4M
A Pharmacologic Approach to Prevent Daptomycin Resistance in VRER01AI121400 · NIAID · WAYNE STATE UNIVERSITY · PI RYBAK, MICHAEL JOSEPH · 2016 to 2020
$1.9M
Impact of daptomycin dose exposure on biofilm embedded Enterococci resistanceR21AI109266 · NIAID · WAYNE STATE UNIVERSITY · PI RYBAK, MICHAEL JOSEPH · 2014 to 2015
$380k
NIAID NIH HHS R01 AI041513NIAID NIH HHS R01 AI106987NIAID NIH HHS R01 AI121400NIAID NIH HHS R21 AI109266
6 · The paper itself

Abstract

Among the viridans group streptococci, the

Indexed as

AnimalsAnti-Bacterial AgentsDaptomycinDrug Resistance, BacterialDrug Therapy, CombinationEndocarditis, BacterialGentamicinsHumansMicrobial Sensitivity TestsRabbitsStreptococcal InfectionsStreptococcus mitisAnti-Bacterial AgentsDaptomycinGentamicinsdaptomycinexperimental endocarditisfitnessgentamicinhigh-level daptomycin resistanceStreptococcus mitis groupvirulence

Identifiers

PMID28264848
PMCPMC5404581
OpenAlexW2594714077

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.